Gundicha Pharmaceuticals Private Limited
About Gundicha Pharmaceuticals Private Limited
Data last updated:
Gundicha Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC303107. Its GSTIN is 27AAHCG1194M1Z7 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Das and Mitali Ajay Das.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at D – 405 Kailash Industrial Complex Veer Savarkar Marg Park Site Vikhroli (W), Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.09 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹8.19 Lakh (net margin -115.4%) and EBITDA of -₹8.15 Lakh (EBITDA margin -114.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gundicha Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD – 405 Kailash Industrial Complex Veer Savarkar Marg Park Site Vikhroli (W), Mumbai, Maharashtra, India – 400079
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gundicha Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gundicha Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gundicha Pharmaceuticals Private Limited, buy the company report.
Financials of Gundicha Pharmaceuticals Private Limited
FY 2020 filings availableGundicha Pharmaceuticals Private Limited reported revenue of ₹7.09 Lakh (down 7% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year. EBITDA fell 725% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹7.09 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹8.15 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹8.19 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -114.9% | ||
| Net Profit Margin | -115.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Gundicha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gundicha Pharmaceuticals Private Limited
Gundicha Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Das | Director | 19 Dec 2017 | 8 Years 10 Months | Current |
| Mitali Ajay Das | Director | 11 Jan 2020 | 6 Years 10 Months | Current |
Peer comparison
Gundicha Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Svizera Healthcare Private Limited | ₹7.1 Lakh (FY 2023) | Mumbai, Maharashtra, India | ||||
| Gundicha Pharmaceuticals Private Limitedthis company | ₹7.09 Lakh (FY 2020) | -₹8.19 Lakh | -115.4% | -7.0% | Mumbai, Maharashtra, India | |
| Lionise Pharmaceuticals Private Limited | ₹7.09 Lakh (FY 2021) | 450.0% | New Delhi, Delhi, India | |||
| Welsave Pharmaceuticals Private Limited | ₹7.07 Lakh (FY 2025) | 70.0% | Delhi, India | |||
| Cradel Pharmaceuticals Pvt Ltd | ₹7.07 Lakh (FY 2025) | 15.0% | Pailan Hut, West Bengal, India |
To see the full peer comparison of Gundicha Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gundicha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gundicha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gundicha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG1194M1Z7 | Maharashtra | Active | 09 Feb 2018 |
To see the full GST registrations and return filing status of Gundicha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gundicha Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Mitali Ajay Das ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Gundicha Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2017 (9+ years old) and is registered under CIN U74999MH2017PTC303107.
Gundicha Pharmaceuticals has 2 current directors:
- Ajay Das - Director
- Mitali Ajay Das - Director
The latest financial statements of Gundicha Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Gundicha Pharmaceuticals is 27AAHCG1194M1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gundicha Pharmaceuticals is U74999MH2017PTC303107. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gundicha Pharmaceuticals was incorporated on 19 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gundicha Pharmaceuticals by revenue are Svizera Healthcare Private Limited, Lionise Pharmaceuticals Private Limited, Welsave Pharmaceuticals Private Limited, Cradel Pharmaceuticals Pvt Ltd, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mitali Ajay Das ceased to be Additional Director on 31 Dec 2020. Mitali Ajay Das was appointed as Director on 11 Jan 2020. Muktikanta Mohanty ceased to be Director on 11 Jan 2020. Gundicha Pharmaceuticals has 4 board changes on record in total.
The registered office of Gundicha Pharmaceuticals is at D – 405 Kailash Industrial Complex Veer Savarkar Marg Park Site Vikhroli W, Mumbai, Maharashtra, India – 400079.
Gundicha Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Gundicha Pharmaceuticals is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
